Queensberry Consulting is developing Metabolica — a clinical point-of-care insulin diagnostic platform enabling clinicians to identify metabolic syndrome 5–10 years before standard markers become abnormal.
We are a Margaret River-based technology and biomedical innovation company founded by Craig, Cinde, and Kirra Fisher. We are building Metabolica — a clinically validated, TGA-approved metabolic diagnostic platform for use by GPs, anaesthetists, exercise physiologists, and preventive health practitioners across Australia.
Fasting insulin is the earliest measurable indicator of metabolic dysfunction — detectable 10–15 years before diagnosis. Yet it is absent from every routine clinical blood panel in Australia. Clinicians have no accessible, real-time tool to measure it outside a laboratory.
Metabolica combines a point-of-care insulin biosensor with wearable biometric data and an AI-powered metabolic risk prediction layer — giving clinicians a validated, accessible metabolic assessment outside a laboratory setting, for the first time.
Metabolica is progressing toward TGA classification as a Software as a Medical Device (SaMD). The biosensor hardware pathway uses the Lumos Diagnostics TGA-approved reader combined with the Vedalab CE-marked insulin lateral flow assay cartridge, with combined system validation and TGA approval as funded project deliverables.
Queensberry Consulting has its roots in over two decades of technology innovation from regional Western Australia. The company was founded by Craig and Cinde Fisher in Margaret River — the same team behind one of regional Australia's most successful technology platforms.
Craig and Cinde Fisher co-founded and developed BookEasy — an online reservation and management platform built specifically for Australian Visitor Centres. Starting in Margaret River, BookEasy scaled nationally to become the platform used by the majority of Visitor Centres across Australia, with over 150 centres on the system and a team of 25 staff. It was one of the first cloud-based booking platforms developed in regional WA. BookEasy demonstrated that world-class technology products could be conceived, built, and commercialised from a regional Australian base.
Following BookEasy, Craig and Cinde established Queensberry Consulting as a technology and innovation consultancy. Over the following decade the company delivered IT strategy, application development, environmental data management, and software solutions across a range of industries in the South West WA region. In 2022, with Craig completing postgraduate research in biomedical science and the convergence of biosensor technology, wearable devices, and AI capability, the company pivoted its focus to health technology — and Metabolica was born.
The same founding team, the same regional WA base, and the same philosophy — identify a genuine market gap, build a technically rigorous solution, and scale it nationally. BookEasy proved the model works. Metabolica is the next chapter.
The first platform globally to combine real-time point-of-care insulin measurement, multi-device wearable biometric data, and AI-powered metabolic risk prediction in a single clinician-accessible platform.
The Lumos Diagnostics POC reader measures fasting insulin from a single blood drop in under 5 minutes — at the point of care, no laboratory required.
Continuous glucose, HRV, sleep quality and activity data pulled via API from 15+ wearable platforms including Garmin, Apple Health, Oura, Whoop and Dexcom.
Combined insulin and biometric data is processed by a machine learning model generating a personalised metabolic risk profile, updated in real time.
Results displayed in a secure clinician-accessible dashboard, enabling remote monitoring, trend analysis, and metabolic risk assessment over time.
In-clinic metabolic screening and remote monitoring for at-risk patients.
Perioperative metabolic risk assessment — insulin resistance as a modifiable surgical risk factor.
Workforce metabolic health baseline and evidence-based prevention program support.
Population health monitoring for community sport, regional health, and chronic disease prevention.
Queensberry Consulting is led by three directors with complementary expertise across biomedical science, software engineering, financial management, and technology commercialisation.
We welcome enquiries from practitioners, corporates, research partners, and investors.
Address
47 Sheridan Road, Margaret River WA 6285
Email
[email protected]
Phone
0401 557 671
Platform
metabolica.app
ABN
78 108 548 269
If you are a GP, anaesthetist, exercise physiologist, or metabolic health specialist interested in the Metabolica platform for clinical use or the validation study, please email [email protected] with the subject line Practitioner Enquiry.
For CRC-P partnership, FHRI research collaboration, or corporate wellness pilot enquiries, please email with the subject line Research Partnership or Corporate Enquiry.